TG Therapeutics Inc (TGTX)

Exchange
NASDAQ
Symbol
TGTX
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company is headquartered in New York, New York.
Country
USA

Stock price

At close: September 22, 2025

  • Open
    32.50
  • High
    35.07
  • Low
    32.29
  • Close
    34.97
  • Volume
    3,437,970

Financial ratios

Dec 31, 2024